Skip to search formSkip to main contentSkip to account menu

Medrogestone

Known as: Medrogestone [Chemical/Ingredient], Pregna-4,6-diene-3,20-dione, 6,17-dimethyl- 
6,17-Dimethylpregna-4,6-diene-3,20-dione. A synthetic progestational hormone with actions similar to those of progesterone. It is used in the… 
National Institutes of Health

Related topics

Related topics

12 relations
AY 62022In Bloodagonistsanalogs & derivatives

Broader (1)

Antineoplastic Agents, Hormonal

Narrower (3)

ColproColproneProthil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin.
To investigate the effect of medrogestone on bone mineral density (BMD) and bone turnover under conditions of estrogen withdrawal… 
2002
2002
Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women.
1999
1999
The effects of six months of treatment with a low‐dose of conjugated oestrogens in menopausal women
Hormone replacement therapy (HRT) is usually prescribed as medium‐ to high‐dose formulations. Little is known, however, about… 
1999
1999
Antioxidant effect of short-term hormonal treatment in postmenopausal women.
1998
1998
Change in body weight after hormone replacement therapy in postmenopausal women is dependent on basal circulating leptin.
1997
1997
Bone effects of transdermal hormone replacement therapy in postmenopausal women as evaluated by means of ultrasound: an open one-year prospective study.
1982
1982
Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
1978
1978
An improved method for extraction and determination of prostate concentrations of endogenous androgens.
1977
1977
Effects of testosterone, testosterone metabolites and anti-androgens on the function of the male accessory glands in the rabbit and rat.
The androgenic potencies of testosterone, 5alpha-dihydrotestosterone, 5alpha-androstane-3alpha,17beta-diol and 5alpha-androstane… 
1971
1971
Treatment of benign prostatic hypertrophy with medrogestone
Twenty‐four patients with established benign prostaue hypertrophy (BPH) uiere treated at random in a double‐blind manner with one… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)